Core Laboratories N.V. (CLB) Stock: Price, Forecast & Analyst Target
Core Laboratories N.V. (CLB) — MoonshotScore 50/100 (Fair band), calculated Nov 18, 2026. Price $8.40 (-0.59%), as of the Nov 19, 2026 trading session; market cap $385M.
Educational signal · not a buy or sell recommendation · How to read this
Core Laboratories N.V. · CLB · NYSE
Core Laboratories N.V. provides reservoir description and production enhancement services to the oil and gas industry globally. The company operates through two segments: Reservoir Description and Production Enhancement.
Price as of Nov 19, 2026
Key Statistics
MoonshotScore v2 · Core Laboratories (CLB)
FairWhy this rating? Method, drivers & history
Bands for the MoonshotScore: Exceptional 80-100 · Strong 65-79 · Fair 45-64 · Weak below 45.
- Business Quality — Is this a genuinely good business?
- Financial Safety — Could this blow up on me?
- Valuation — Am I paying a fair price?
- Growth Durability — Is the growth real and likely to last?
- Momentum — Is the market already moving on this?
A full valuation, though quality and growth are only middling, and the price trend has turned against it. Business Quality: Average; Financial Safety: Okay; Valuation: Full; Growth Durability: Flat; Momentum: Falling.
- EPS beat 0 of the last 4 reports
- Altman Z 2.51 · Piotroski F 7
- ROE 5.6% · ROA 4.1% · current ratio 2.19
Holding back: weak price trend
What has the MoonshotScore done over time?
| Recorded | Score | Band |
|---|---|---|
| 51 | Fair | |
| 51 | Fair | |
| 51 | Fair | |
| 50 | Fair | |
| 50 | Fair | |
| 50 | Fair |
Daily score refresh is delayed. This is the last recorded calculation.
Calculation uses the most recent completed US trading session. Live price changes do not update the score immediately.
Computed · How the MoonshotScore is computed →
Price & valuation
| Measure | Value | As of |
|---|---|---|
| Latest provided price | $8.40 | |
| Change on the day | -0.59% | |
| 52-week range | $8.40 – $20.36 | |
| Market capitalisation | $385M | — |
| Price / earnings (trailing) | 24.68 | |
| Shares traded on the day | 635.9K |
Price & events
Other perspectives
Council score for Core Laboratories (CLB): perspectives
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
5-Factor Breakdown
Legends Council
5 lenses, 5 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: Nov 20, 2026
Munger's Mindset
Balance Sheet & Valuation
Read on: Nov 20, 2026
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
The Munger lens reads the current price as undervalued against its own estimate of value.
Readings on this page are from Nov 21, 2026, except a card that shows its own read date.
What is Core Laboratories (CLB), and what does it report?
Short answer
A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. Core Laboratories N.V. (CLB) is listed on NYSE. It employs 3,300 people and is led by Lawrence V. Bruno. The market values it at $385M.
What do the latest results show for Core Laboratories (CLB)?
Short answer · as of
Against analyst estimates the company has EPS beat 0 of the last 4 reports.
Quarterly income statement — 4 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Sep 2025 | $135M | $14M | $0.30 (diluted) |
| Q4 FY2025 | $138M | $5M | $0.11 (diluted) |
| Q1 FY2026 | $122M | -$789,000 | -$0.02 (diluted) |
| Q2 FY2026 | $125M | $6M | $0.13 (diluted) |
What are the financial strengths and risks for Core Laboratories (CLB)?
Short answer
What is holding it back is weak price trend. The distress and quality screens read Altman Z 2.51 · Piotroski F 7. Trailing ratios: ROE 5.6% · ROA 4.1% · current ratio 2.19.
What should you watch next at Core Laboratories (CLB)?
Short answer · as of
Current published price targets run low $21.00 · high $21.00 · consensus $21.00 · median $21.00 against a quoted price of $8.40 (as of Nov 19, 2026).
What the records here don't tell us
- No forward revenue or earnings estimate is on file.
- The next earnings date is not yet scheduled in the calendar we read.
Checked against the records this page reads, on the dates shown above.
How does Core Laboratories compare with its peers?
Short answer
Core Laboratories's score ranks 10th of 13 in the bounded comparison shown, against 12 same-model peers. These are company scores, not expected investment returns. The set lists named competitors first, then companies in the same data-provider industry classification closest in market value; that classification is the provider's, not our judgment of business similarity.
| Company | Price | Market value | Score |
|---|---|---|---|
| $3.91 Nov 19, 2026 | $166M | 90 5-pillar Nov 18, 2026 | |
| $4.81 Nov 19, 2026 | $209M | 84 5-pillar Nov 18, 2026 | |
| $31.74 Nov 19, 2026 | $26.3B | 66 5-pillar Nov 18, 2026 | |
| $8.40 Nov 19, 2026 | $705M | 66 5-pillar Nov 18, 2026 | |
| $11.30 Nov 19, 2026 | $268M | 64 5-pillar Nov 18, 2026 | |
| $72.19 Nov 19, 2026 | $828M | 63 5-pillar Nov 18, 2026 | |
| $47.90 Nov 19, 2026 | $70.7B | 60 5-pillar Nov 18, 2026 | |
| $28.82 Nov 19, 2026 | $372M | 58 5-pillar Nov 18, 2026 | |
| $46.67 Nov 19, 2026 | $46.4B | 53 5-pillar Nov 18, 2026 | |
| Core Laboratories (CLB) — this page | $8.40 | $385M | 50 |
| $7.65 Nov 19, 2026 | $458M | 46 5-pillar Nov 18, 2026 | |
| $24.50 Nov 19, 2026 | $889M | 42 5-pillar Nov 18, 2026 | |
| $8.31 Nov 19, 2026 | $222M | 34 5-pillar Nov 18, 2026 |
Only 5-pillar scores are ranked together. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.
The records behind this page
Analyst targets & estimates
What analysts have on file
- Price target, low to high
- $21.00 – $21.00
- Consensus target
- $21.00
- Median target
- $21.00
Consensus record · Captured .
Measured against a quoted price of $8.40 (as of Nov 19, 2026).
Insider activity
Form 4 records via FMP · Of the newest 100 records, those within the last 180 days, newest dated Oct 1, 2026
- Transactions
- 16
- Identified insiders
- 3
- Purchases
- 1
- Sales
- 0
- Other transactions
- 15
Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.
Who holds the shares?
Institutional ownership reported through 13F filings.
Tracked investors
Which of the 16 named investors we follow held CLB in their latest 13F filing, and what they did against the filing before it.
None of the 16 tracked investors reported CLB in their latest 13F filing.
How to read these figures
These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.
What has been published about Core Laboratories (CLB)?
Core Laboratories Stock: Key Questions Answered
These answers are editorial: 2 of these 9 answers are drawn from the CLB research dossier (written May 10, 2026 by gemini-2.0-flash); the other 7 are question templates that restate figures shown above. Figures in this section are not part of the source register.
What does the MoonshotScore mean for CLB?
CLB carries the MoonshotScore stated above — the Fair band. This is an educational research signal, not a buy or sell recommendation. The number comes from the five-pillar engine (business quality, financial safety, valuation, growth durability, momentum), re-ranked daily against sector peers. Core Laboratories N.V. provides reservoir description and production enhancement services to the oil and gas industry globally.
Is CLB a good stock to buy?
Stock Expert AI does not rate CLB buy, sell or hold. Core Laboratories N.V. carries a MoonshotScore, in the Fair band, a research rating against its peers rather than a forecast. Whether it fits is your call: check what it sells, whether it earns and what the price assumes. This is educational content, not investment advice.
What is the CLB stock price today?
The last price recorded for Core Laboratories N.V. (CLB), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.
What is the CLB price target?
The analyst consensus price target for Core Laboratories N.V. (CLB), with its range and the date it was captured from FMP, is listed under Analyst targets & estimates on this page. Targets are analyst opinions and change often; they are not a Stock Expert AI forecast.
What does Core Laboratories N.V. do?
Core Laboratories N.V. is a leading provider of reservoir description and production enhancement services to the oil and gas industry.
What are the main risks for CLB?
Core Laboratories N.V. faces several risks, including fluctuations in oil prices, which can impact drilling and production activity. Competition from larger oilfield service companies poses a threat to its market share.
What are the key factors to evaluate for CLB?
Core Laboratories N.V. (CLB) holds a MoonshotScore in the moderate range. To weigh it, compare the trailing P/E under Price & valuation with the analyst view under Analyst targets & estimates on this page. Partnerships with Oil and Gas Companies: Forming strategic partnerships with major oil and gas companies can provide access to new projects and markets. Not financial advice.
How frequently does CLB data refresh on this page?
CLB's price is the last quote we recorded, from the Nov 19, 2026 trading session. Pages are served from a cache, so the copy you are reading can lag that quote. The quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 is recalculated from the most recent completed US trading session; the score's own date shows its last successful run.
What has driven CLB's recent stock price performance?
Core Laboratories N.V. (CLB) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Strong market position in reservoir description and production enhancement. See the News tab for the latest drivers. Past performance does not predict future results.
Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated May 10, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources: the source register lists the 18 figures on this page — 11 from Financial Modeling Prep (FMP), 6 with no recorded source and 1 from Stock Expert AI's own score and rank. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.
Publication details and research sources
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com